ANRO · Alto Neuroscience, Inc.

$33.95 -0.31 (-0.89%)

Market Cap

$1.34B

39.24M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Amit Etkin	M.D., Ph.D. President, Chief Executive Officer, and Chair of the Board	$650,671	$220,000	—	$934,186	$358,072	$25,558	$2,188,487
Nicholas Smith	Chief Financial Officer and Chief Business Officer	$493,720	$220,000	—	$594,723	$222,300	$10,842	$1,541,585
Michael Hanley	Chief Operating Officer	$488,800	—	—	$517,598	$195,520	$11,010	$1,212,928

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Amit Etkin	M.D., Ph.D. President, Chief Executive Officer, and Chair of the Board	$603,050	—	$516,500	$2,553,350	$368,401	$24,547	$4,065,848
Michael Hanley	Chief Operating Officer	$283,205	—	—	$1,876,263	$201,160	$82,000	$2,442,628
Nicholas Smith	Chief Financial Officer and Chief Business Officer	$466,511	—	$284,997	$1,030,500	$203,300	$10,656	$1,995,964

Executive changes

Person	Role	Change	Effective	Filed
Andrew Miller, Ph.D.	member of the Board	Appointed	2026-05-27	2026-05-28
Ramiro (Raymond) Sanchez, M.D.	member of the Board	Appointed	2025-08-12	2025-08-13
Michael Hanley	Chief Operating Officer	Appointed	2024-05-20	2024-05-21
Maha Radhakrishnan, M.D.	member of the Board	Appointed	2024-03-08	2024-03-11

Key facts CIK 1999480 CUSIP 02157Q109 13F (30d) 115 filings 112 filers Visit website Investor relations